Stay updated with breaking news from Director Patrick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VYNE Therapeutics Inc. (NASDAQ:VYNE – Get Rating) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totalling 91,900 shares, a decline of 55.6% from the April 30th total of 206,800 shares. Currently, 2.9% of the shares of the company are sold short. Based on […]
American Vanguard Co. (NYSE:AVD – Get Rating)’s stock price shot up 4.2% during mid-day trading on Friday . The company traded as high as $17.78 and last traded at $17.71. 99,881 shares changed hands during mid-day trading, a decline of 22% from the average session volume of 128,107 shares. The stock had previously closed at […]
American Vanguard Co. (NYSE:AVD – Get Rating) shares shot up 4.2% during trading on Friday . The stock traded as high as $17.78 and last traded at $17.71. 99,881 shares traded hands during mid-day trading, a decline of 22% from the average session volume of 128,107 shares. The stock had previously closed at $17.00. Analyst […]
VYNE Therapeutics (NASDAQ:VYNE – Get Rating) had its price target lifted by Cantor Fitzgerald from $5.00 to $9.00 in a report released on Friday morning, The Fly reports. Separately, HC Wainwright reaffirmed a buy rating and set a $28.00 target price on shares of VYNE Therapeutics in a report on Wednesday, April 19th. VYNE Therapeutics […]
American Vanguard Co. (NYSE:AVD – Get Rating) Director Patrick E. Gottschalk acquired 20,000 shares of American Vanguard stock in a transaction on Monday, May 15th. The shares were bought at an average price of $16.74 per share, with a total value of $334,800.00. Following the purchase, the director now directly owns 33,231 shares in the […]